SCHEMBL6499962

SCHEMBL6499962

CSc1ccc(/C=C/C(=O)N2CCC(C(=O)N[C@@H](CNC(=O)c3cccnc3)C(=O)O)CC2)c(Cl)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 7/20 0.45
ITGB2 P05107 6/20 0.45
ICAM1 P05362 6/20 0.45
CAPN1 P07384 4/20 0.40
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499971 1.00 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6499982 1.00 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6495908 0.92 ITGAL (0.51) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL8297366 0.92 ITGAL (0.51) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6495913 0.92 ITGAL (0.51) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6506835 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6506844 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6506856 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6500234 0.88 ITGAL (0.46) ITGALITGB2ICAM1CAPN1MEN1
SCHEMBL6500228 0.88 ITGAL (0.46) ITGALITGB2ICAM1CAPN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed